Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
CG Oncology Inc | CGON | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
33,90 | 31,935 | 35,26 | 32,11 | 33,89 |
Actualités Recentes
Date | Heure | Source | Titre |
---|---|---|---|
18/6/2024 | 14:00 | GLOBE | CG Oncology Initiates Expanded Access Program for.. |
06/6/2024 | 18:14 | GLOBE | CG Oncology Announces Nature Medicine Publication of Final.. |
24/5/2024 | 14:15 | EDGAR2 | Form 8-K - Current report |
24/5/2024 | 14:00 | GLOBE | CG Oncology to Present Positive Final Results from Phase 2.. |
09/5/2024 | 14:10 | EDGAR2 | Form 8-K - Current report |
09/5/2024 | 14:00 | GLOBE | CG Oncology Reports First Quarter 2024 Financial Results and.. |
09/5/2024 | 12:07 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
03/5/2024 | 17:23 | GLOBE | Cretostimogene Monotherapy Demonstrated 75.2% Complete.. |
26/4/2024 | 14:00 | GLOBE | CG Oncology to Host Virtual Investor Event on Friday, May 3,.. |
24/4/2024 | 16:00 | GLOBE | CG Oncology to Unveil Encouraging Results on Cretostimogene.. |
28/3/2024 | 13:00 | GLOBE | CG Oncology to Present Results on Cretostimogene at the AUA.. |
27/2/2024 | 14:00 | GLOBE | CG Oncology Announces First Patient Dosed in PIVOT-006 Phase.. |
30/1/2024 | 13:00 | BW | CG Oncology Announces Closing of Initial Public Offering and.. |